<clinical_study>
<study_id>
<org_name>
  Valeant
</org_name>
<org_full_name>
  Valeant Research &amp; Development
</org_full_name>
<org_study_id>
  VRX-RET-E22-303
</org_study_id>
<nct_id>
  NCT00310375
</nct_id>
</study_id>
<brief_title>
<textblock>
  Open-Label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
</textblock>
</brief_title>
<official_title>
<textblock>
  A Multicenter, Open-Label, Long-Term, Safety, Tolerability and Efficacy Study of Retigabine in Adult Epilepsy Patients With Partial-Onset Seizures (Extension of Study VRX-RET-E22-301)
</textblock>
</official_title>
<study_sponsor>
<lead_sponsor>
<agency>
  Valeant Research &amp; Development
</agency>
</lead_sponsor>
</study_sponsor>
<oversight_info>
<regulatory_authority>
  United States: Food and Drug Administration
</regulatory_authority>
</oversight_info>
<brief_summary>
<textblock>
  The purpose of this study is to evaluate the safety and tolerability of long-term therapy with retigabine administered as adjunctive therapy in adult epilepsy patients with partial-onset seizures, who completed the VRX-RET-E22-301 double-blind study.  The efficacy of long-term treatment with retigabine and patient quality of life will also be assessed.
</textblock>
</brief_summary>
<detailed_descr>
<textblock>
  This Phase 3 trial is an open-label extension study of the placebo-controlled, double-blind VRX-RET-E22-301 trial.  Patients who have completed the VRX-RET-E22-301 trial and who meet inclusion and exclusion criteria will be treated with 600-1200 mg/day of retigabine as an adjunct therapy to their current antiepileptic drugs (AEDs) or vagal nerve stimulation.  Treatment will be continued until retigabine is commercially available, or until the program is discontinued.  Patients will be recruited from 45-50 sites in the United States, Canada, Mexico, Brazil, and Argentina.  The safety and tolerability of long-term therapy with retigabine administered as adjunctive therapy in adult epilepsy patients with partial-onset seizures will be evaluated.  In addition, the efficacy of long-term treatment with retigabine and patient quality of life will be assessed.
</textblock>
</detailed_descr>
<status_block>
<status>
  Recruiting
</status>
<date>
2006-06 
</date>
</status_block>
<start_date>
<date>
  2006-05
</date>
</start_date>
<end_date>
<date>
</date>
</end_date>
<last_follow_up_date>
<date>
</date>
</last_follow_up_date>
<last_data_entry_date>
<date>
</date>
</last_data_entry_date>
<phase_block>
<phase>
  Phase 3
</phase>
</phase_block>
<study_type>
  Interventional
</study_type>
<design>
  Treatment
</design>
<design>
  Non-Randomized
</design>
<design>
  Open Label
</design>
<design>
  Uncontrolled
</design>
<design>
  Single Group Assignment
</design>
<design>
  Safety/Efficacy Study
</design>
<primary_outcome>
  Percentage change in the monthly seizure rate from the baseline phase to the open-label treatment phase.
</primary_outcome>
<primary_outcome>
  Vital signs
</primary_outcome>
<primary_outcome>
  Weight
</primary_outcome>
<primary_outcome>
  Clinical Lab Evaluations (blood chemistry, hematology, and urinalysis)
</primary_outcome>
<primary_outcome>
  12-lead ECGs
</primary_outcome>
<primary_outcome>
  Physical and neurological examinations
</primary_outcome>
<primary_outcome>
  Evaluations of adverse events.
</primary_outcome>
<primary_outcome>
  American Urological Association Symptom Index
</primary_outcome>
<primary_outcome>
  Post-void residual bladder ultrasound
</primary_outcome>
<secondary_outcome>
  Proportion of responders (patients experiencing at least a 50% reduction in seizure frequency) from baseline to the open-label treatment phase.
</secondary_outcome>
<condition>
  Epilepsies, Partial
</condition>
<intervention>
<intervent_type>
  Drug
</intervent_type>
<primary_name>
  Retigabine
</primary_name>
</intervention>
<eligibility>
<criteria>
<textblock>
  Inclusion Criteria:
    - Patient has successfully completed the Maintenance and Transition phases of Study VRX-RET-E22-301 for the treatment of partial-onset seizures
  - Patient is expected to benefit from participation in the study in the opinion of the Investigator.
 
  Exclusion Criteria:
    - Patient meets any of the withdrawal criteria in the previous VRX-RET-E22-301 study or is experiencing an ongoing serious adverse event.
  - Patient is receiving any investigational drug or using any experimental device in addition to Retigabine for treatment of epilepsy or any other medical condition.
  - Patient has any other condition that would prevent compliance with the study procedures or proper reporting of adverse events.
</textblock>
</criteria>
<healthy_volunteers>
  No
</healthy_volunteers>
<patients>
</patients>
<expected_enrollment>
  280
</expected_enrollment>
<gender>
  Both
</gender>
<minimum_age>
  18 Years
</minimum_age>
<maximum_age>
  75 Years
</maximum_age>
</eligibility>
<location>
<facility>
<name>
  Neurology Clinic
</name>
<address>
<city>
  Northport
</city>
<state>
  Alabama
</state>
<zip>
  35476
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Maryann Hannah
</name>
<phone>
  205-333-2626
</phone>
<phone_ext>
</phone_ext>
<email>
  ncpc1325@bellsouth.net
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Alexandre Todorov
</name>
</contact>
</location>
<location>
<facility>
<name>
  North Alabama Neuroscience Research Associates
</name>
<address>
<city>
  Huntsville
</city>
<state>
  Alabama
</state>
<zip>
  35801
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Jennifer Perry
</name>
<phone>
  256-533-3552
</phone>
<phone_ext>
</phone_ext>
<email>
  jperry@clinicforneurology.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Richard Hull
</name>
</contact>
</location>
<location>
<facility>
<name>
  Barrow Neurological Institute
</name>
<address>
<city>
  Phoenix
</city>
<state>
  Arizona
</state>
<zip>
  85013
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Nicole Hank
</name>
<phone>
  602-406-6251
</phone>
<phone_ext>
</phone_ext>
<email>
  nicole.hank@chw.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Steven Chung
</name>
</contact>
</location>
<location>
<facility>
<name>
  Discovery Alliance Inc.
</name>
<address>
<city>
  Phoenix
</city>
<state>
  Arizona
</state>
<zip>
  85015
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Jillian Hurlbut-Styke
</name>
<phone>
  602-335-0300
</phone>
<phone_ext>
  124
</phone_ext>
<email>
  jhurlbut@discoveryalliance.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Avinash Khatter
</name>
</contact>
</location>
<location>
<facility>
<name>
  Clinical Trials Inc.
</name>
<address>
<city>
  Little rock
</city>
<state>
  Arkansas
</state>
<zip>
  72205
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Dusty Hollis-Holderfield
</name>
<phone>
  501-227-6179
</phone>
<phone_ext>
</phone_ext>
<email>
  dholderfield@clinicaltrialsinc.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Victor Biton
</name>
</contact>
</location>
<location>
<facility>
<name>
  University of Southern California -- Keck School of Medicine
</name>
<address>
<city>
  Los Angeles
</city>
<state>
  California
</state>
<zip>
  90033
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Susan Milstein
</name>
<phone>
  323-224-5555
</phone>
<phone_ext>
</phone_ext>
<email>
  smilstei@usc.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Karen Lindsay, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  West Los Angeles VA Healthcare Center
</name>
<address>
<city>
  Los Angeles
</city>
<state>
  California
</state>
<zip>
  90073
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Kimberly Panizzon
</name>
<phone>
  818-744-8252
</phone>
<phone_ext>
</phone_ext>
<email>
  kpanizzon@yahoo.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Roi Wallis
</name>
</contact>
</location>
<location>
<facility>
<name>
  Delta Waves
</name>
<address>
<city>
  Colorado Springs
</city>
<state>
  Colorado
</state>
<zip>
  80918
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Steven H Spillers, MD
</name>
<phone>
  719-955-6481
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Steven H Spillers, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  Lovelace Scientific Resources
</name>
<address>
<city>
  Sarasota
</city>
<state>
  Florida
</state>
<zip>
  34233
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Denise Dorman
</name>
<phone>
  941-379-8810
</phone>
<phone_ext>
</phone_ext>
<email>
  ddorman@lrri.org
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Ronald Aung-Din
</name>
</contact>
</location>
<location>
<facility>
<name>
  University of Florida -- Shands Jacksonville
</name>
<address>
<city>
  Jacksonville
</city>
<state>
  Florida
</state>
<zip>
  32209
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Marc Lojacono
</name>
<phone>
  904-244-9468
</phone>
<phone_ext>
</phone_ext>
<email>
  marc.lojacono@jax.ufl.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  John DeCerce
</name>
</contact>
</location>
<location>
<facility>
<name>
  University of Miami
</name>
<address>
<city>
  Miami
</city>
<state>
  Florida
</state>
<zip>
  33136
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Marinellie Vega
</name>
<phone>
  305-243-5944
</phone>
<phone_ext>
  8
</phone_ext>
<email>
  mvega@epiworld.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Richard Ramsay
</name>
</contact>
</location>
<location>
<facility>
<name>
  McFarland Clinic
</name>
<address>
<city>
  Ames
</city>
<state>
  Iowa
</state>
<zip>
  50010
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Jolene Frette
</name>
<phone>
  515-239-6868
</phone>
<phone_ext>
</phone_ext>
<email>
  jfrette@mcfarlandclinic.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  David Moore
</name>
</contact>
</location>
<location>
<facility>
<name>
  University of Kentucky
</name>
<address>
<city>
  Lexington
</city>
<state>
  Kentucky
</state>
<zip>
  40536
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Yaira Garzon
</name>
<phone>
  859-323-5406
</phone>
<phone_ext>
</phone_ext>
<email>
  yaira.garzon@uky.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Toufic Fakhoury
</name>
</contact>
</location>
<location>
<facility>
<name>
  Henry Ford Hospital
</name>
<address>
<city>
  Detroit
</city>
<state>
  Michigan
</state>
<zip>
  48202
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Sharon McCarthy
</name>
<phone>
  313-916-2214
</phone>
<phone_ext>
</phone_ext>
<email>
  sharonm@neuro.hfh.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  David Burdette
</name>
</contact>
</location>
<location>
<facility>
<name>
  Minnesota Epilepsy Group, P.A.
</name>
<address>
<city>
  St. Paul
</city>
<state>
  Minnesota
</state>
<zip>
  55102
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Gail Sherman
</name>
<phone>
  651-241-5289
</phone>
<phone_ext>
</phone_ext>
<email>
  gsherman@mnepilepsy.net
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Patricia Penovich
</name>
</contact>
</location>
<location>
<facility>
<name>
  The Comprehensive Epilepsy Care Center for Children and Adults
</name>
<address>
<city>
  Chesterfield
</city>
<state>
  Missouri
</state>
<zip>
  63017
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Cecelia Fields
</name>
<phone>
  314-453-9300
</phone>
<phone_ext>
  35
</phone_ext>
<email>
  werosenfeld@msn.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  William Rosenfeld
</name>
</contact>
</location>
<location>
<facility>
<name>
  Asheville Neurology Specialists
</name>
<address>
<city>
  Asheville
</city>
<state>
  North Carolina
</state>
<zip>
  28801
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Susan Woodard, CCRC
</name>
<phone>
  828-210-9308
</phone>
<phone_ext>
</phone_ext>
<email>
  swoodard@ashneuro.com
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Robert Armstrong
</name>
</contact>
</location>
<location>
<facility>
<name>
  Medical University of Ohio at Toledo
</name>
<address>
<city>
  Toledo
</city>
<state>
  Ohio
</state>
<zip>
  43614
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Andrea Korsnack, RN, CNRN
</name>
<phone>
  419-383-3801
</phone>
<phone_ext>
</phone_ext>
<email>
  akorsnack@mco.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Imran Ali
</name>
</contact>
</location>
<location>
<facility>
<name>
  OSU Harding Hospital
</name>
<address>
<city>
  Columbus
</city>
<state>
  Ohio
</state>
<zip>
  43210-1250
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  James L Moore
</name>
<phone>
  614-292-1043
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  James L Moore
</name>
</contact>
</location>
<location>
<facility>
<name>
  Neurological Clinic
</name>
<address>
<city>
  Portland
</city>
<state>
  Oregon
</state>
<zip>
  97210
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Norman K So
</name>
<phone>
  503-229-7606
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Norman K So
</name>
</contact>
</location>
<location>
<facility>
<name>
  Oregon Neurology PC
</name>
<address>
<city>
  Tualatin
</city>
<state>
  Oregon
</state>
<zip>
  97062
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
<contact>
<name>
  Paul R Ash, MD
</name>
<phone>
  503-692-2850
</phone>
<phone_ext>
</phone_ext>
<email>
  ashpr@comcast.net
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Paul R Ash, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  Milton S. Hershey Medical Center
</name>
<address>
<city>
  Hershey
</city>
<state>
  Pennsylvania
</state>
<zip>
  17033
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Paul McCabe
</name>
<phone>
  717-531-5600
</phone>
<phone_ext>
</phone_ext>
<email>
  pmccabe@psu.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Paul McCabe
</name>
</contact>
</location>
<location>
<facility>
<name>
  Vanderbilt University Medical Center
</name>
<address>
<city>
  Nashville
</city>
<state>
  Tennessee
</state>
<zip>
  37212
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Diana Jackson
</name>
<phone>
  615-936-0209
</phone>
<phone_ext>
</phone_ext>
<email>
  diana.jackson@vanderbilt.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Bassell Abou-Khalil
</name>
</contact>
</location>
<location>
<facility>
<name>
  Neurological Clinic of Texas
</name>
<address>
<city>
  Dallas
</city>
<state>
  Texas
</state>
<zip>
  75230
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
 Recruiting 
</status>
<contact>
<name>
  Robert F Leroy
</name>
<phone>
  972-566-7690
</phone>
<phone_ext>
</phone_ext>
<email>
  rfleroy@airmail.net
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Robert Leroy
</name>
</contact>
</location>
<location>
<facility>
<name>
  Memorial  Hermann Hospital
</name>
<address>
<city>
  Houston
</city>
<state>
  Texas
</state>
<zip>
  77030
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Jeremy D Slater, MD
</name>
<phone>
  713-500-7106
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Jeremy D Slater, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  Virginia Commonwealth University Medical Center
</name>
<address>
<city>
  Richmond
</city>
<state>
  Virginia
</state>
<zip>
  23298
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
 Recruiting 
</status>
<contact>
<name>
  Alan R Towne, MD
</name>
<phone>
  804-828-9869
</phone>
<phone_ext>
</phone_ext>
<email>
  atowne@hsc.vcu.edu
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Alan R Towne, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital Italiano de Buenos Aires
</name>
<address>
<city>
  Capital  Federal
</city>
<state>
  CBA
</state>
<zip>
  C1181ACH
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Stella Maris Valiensi
</name>
<phone>
  54-11-49590322
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Stella Maris Valiensi
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital General de Agudos &quot;Dr. Teodoro Alvarez&quot;
</name>
<address>
<city>
  Capital Federal
</city>
<state>
  CBA
</state>
<zip>
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Veronica Campanille
</name>
<phone>
  54-11-54009507
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Veronica Campanille
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital General de Agudos &quot;Dr. J.M. Ramos Mejia&quot;
</name>
<address>
<city>
  Capital Federal
</city>
<state>
  CBA
</state>
<zip>
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Silvia Kochen
</name>
<phone>
  54-11-49326101
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Silvia Kochen
</name>
</contact>
</location>
<location>
<facility>
<name>
  Fundacion Lennox
</name>
<address>
<city>
  Cordoba
</city>
<state>
  CRD
</state>
<zip>
  5000
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Roberto Giobellina
</name>
<phone>
  54-351-4235128
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Roberto Giobellina
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital Privado Centro Medico de Cordoba
</name>
<address>
<city>
  Cordoba
</city>
<state>
  CRD
</state>
<zip>
  X5016KEH
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Maria Jesus Frias
</name>
<phone>
  54-351-4688216
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Maria Jesus Frias
</name>
</contact>
</location>
<location>
<facility>
<name>
  Sanatorio del Salvador II
</name>
<address>
<city>
  Cordoba
</city>
<state>
  CRD
</state>
<zip>
  5000
</zip>
<country>
  Argentina
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Leonardo Kremer
</name>
<phone>
  54-351-4528888
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Leonardo Kremer
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital Universitario Prof Edgard Santos -- UFBA
</name>
<address>
<city>
  Salvador
</city>
<state>
  BA
</state>
<zip>
  40110-060
</zip>
<country>
  Brazil
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Marielza  Fernan Veiga
</name>
<phone>
  55-71-3339-6253
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Marielza Fernan Veiga
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital das Clinicas da Fac de Medicina de Sao Paulo
</name>
<address>
<city>
  Sao Paulo
</city>
<state>
  SP
</state>
<zip>
  05403-900
</zip>
<country>
  Brazil
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Maria Luiza Gir De Manreza
</name>
<phone>
  55-11-3069-6106
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Maria Luiza Gir De Manreza
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital das Clinicas de Ribeirao Preto -- Universidade de Sa Neurologia
</name>
<address>
<city>
  Ribeirao Preto
</city>
<state>
  SP
</state>
<zip>
  14048-900
</zip>
<country>
  Brazil
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Americo Ceiki Sakamoto
</name>
<phone>
  55-16-633-9000
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Americo Ceiki Sakamoto
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital Sao Paulo -- Escola Paulista de Medicina -- UNIFESP
</name>
<address>
<city>
  Sao Paulo
</city>
<state>
  SP
</state>
<zip>
  04024 002
</zip>
<country>
  Brazil
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Elza Marcia Tar Yacubian
</name>
<phone>
  55-11-5576-4541
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Elza Marcia Tar Yacubian
</name>
</contact>
</location>
<location>
<facility>
<name>
  Foothills Medical Center
</name>
<address>
<city>
  Calgary
</city>
<state>
  Alberta
</state>
<zip>
  T2N 2T9
</zip>
<country>
  Canada
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Neelan Pillay
</name>
<phone>
  403-944-4556
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Neelan Pillay
</name>
</contact>
</location>
<location>
<facility>
<name>
  Glenrose Rehabilitation Center
</name>
<address>
<city>
  Edmonton
</city>
<state>
  Alberta
</state>
<zip>
  T5G 0B7
</zip>
<country>
  Canada
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Corinne McMillan, M.S.
</name>
<phone>
  780-735-8886
</phone>
<phone_ext>
</phone_ext>
<email>
  corinnemcmillan@cha.ab.ca
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Elout Starreveld
</name>
</contact>
</location>
<location>
<facility>
<name>
  Health Sciences Centre
</name>
<address>
<city>
  St. John&apos;s
</city>
<state>
  Newfoundland and Labrador
</state>
<zip>
  A1B 3V6
</zip>
<country>
  Canada
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Abayomi Ogunyemi
</name>
<phone>
  709-777-6585
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Abayomi Ogunyemi
</name>
</contact>
</location>
<location>
<facility>
<name>
  CHUM -- H&#244;pital Notre-Dame
</name>
<address>
<city>
  Montr&#233;al
</city>
<state>
  Quebec
</state>
<zip>
  H2L 4M1
</zip>
<country>
  Canada
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Patrick Cossette
</name>
<phone>
  514-890-8000
</phone>
<phone_ext>
  25523
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Patrick Cossette
</name>
</contact>
</location>
<location>
<facility>
<name>
  Centro Medico
</name>
<address>
<city>
  Mexico
</city>
<state>
  DF
</state>
<zip>
  03229
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Lilia Nunez Orozco
</name>
<phone>
  52-55-52005003
</phone>
<phone_ext>
  4292
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Lilia Nunez Orozco
</name>
</contact>
</location>
<location>
<facility>
<name>
  CIF BIOTEC, Medica Sur
</name>
<address>
<city>
  Tlalpan
</city>
<state>
  DF
</state>
<zip>
  14050
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Gloria Llamosa-Garcia Velazquez
</name>
<phone>
  52-55-54240110
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Gloria Llamosa-Garcia Velazquez
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital de Psiquiatria San Fernando, IMSS
</name>
<address>
<city>
  Mexico
</city>
<state>
  DF
</state>
<zip>
  14050
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Marcela Perez-Arreola
</name>
<phone>
  52-55-56060391
</phone>
<phone_ext>
</phone_ext>
<email>
  marcelaperezarreola@prodigy.net
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Marcela Perez-Arreola
</name>
</contact>
</location>
<location>
<facility>
<name>
  Instituto Nacional de Neurologia y Neurocirugia
</name>
<address>
<city>
  La Fama
</city>
<state>
  DF
</state>
<zip>
  42690
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Marie-Catherine Woehrlen, MD
</name>
<phone>
  52-55-56063822
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Marie-Catherine Woehrlen, MD
</name>
</contact>
</location>
<location>
<facility>
<name>
  Antiguo Hospital Civil de Guadalajara
</name>
<address>
<city>
  Guadalajara
</city>
<state>
  Jalisco
</state>
<zip>
  44280
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Jose L Ruiz-Sandoval, Dr.
</name>
<phone>
  52 33 36134016
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Jose L Ruiz-Sandoval, Dr.
</name>
</contact>
</location>
<location>
<facility>
<name>
  Hospital Central Dr. Ignacio Morones Prieto
</name>
<address>
<city>
  San Luis Potosi
</city>
<state>
  SLP
</state>
<zip>
  78250
</zip>
<country>
  Mexico
</country>
</address>
</facility>
<status>
  Not yet recruiting
</status>
<contact>
<name>
  Idelfonso Rodriguez
</name>
<phone>
  52-44-48176692
</phone>
<phone_ext>
</phone_ext>
<email>
</email>
</contact>
<contact>
<role>
  Principal Investigator
</role>
<name>
  Idelfonso Rodriguez
</name>
</contact>
</location>
<keyword>
  Partial Seizures
</keyword>
<keyword>
  Complex Partial Seizures
</keyword>
<keyword>
  Epilepsy
</keyword>
<keyword>
  Anticonvulsant
</keyword>
<keyword>
  Potassium Channels
</keyword>
<initial_release_date>
  2006-03-30
</initial_release_date>
<last_release_date>
2006-06-30 
</last_release_date>
</clinical_study>
